ZA201200659B - Pharmaceutical composition of isoniazid - Google Patents
Pharmaceutical composition of isoniazidInfo
- Publication number
- ZA201200659B ZA201200659B ZA2012/00659A ZA201200659A ZA201200659B ZA 201200659 B ZA201200659 B ZA 201200659B ZA 2012/00659 A ZA2012/00659 A ZA 2012/00659A ZA 201200659 A ZA201200659 A ZA 201200659A ZA 201200659 B ZA201200659 B ZA 201200659B
- Authority
- ZA
- South Africa
- Prior art keywords
- isoniazid
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1765MU2009 | 2009-07-31 | ||
| IN1991MU2009 | 2009-09-01 | ||
| PCT/IB2010/001871 WO2011012987A1 (en) | 2009-07-31 | 2010-07-29 | Pharmaceutical composition of isoniazid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201200659B true ZA201200659B (en) | 2012-10-31 |
Family
ID=43528828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2012/00659A ZA201200659B (en) | 2009-07-31 | 2012-01-26 | Pharmaceutical composition of isoniazid |
Country Status (4)
| Country | Link |
|---|---|
| AP (1) | AP2012006119A0 (en) |
| RU (1) | RU2012105674A (en) |
| WO (1) | WO2011012987A1 (en) |
| ZA (1) | ZA201200659B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY174007A (en) | 2013-07-26 | 2020-03-03 | Sanofi Sa | Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation |
| RU2694056C2 (en) * | 2013-07-26 | 2019-07-09 | Санофи | Anti-tuberculosis stable pharmaceutical composition in form of dispersible tablet containing granulated isoniazid and granulated rifapentine, and method for preparing it |
| US20210100786A1 (en) | 2018-04-05 | 2021-04-08 | Cipla Limited | Pharmaceutical Formulations |
| CN112438951A (en) * | 2019-08-28 | 2021-03-05 | 重庆华邦制药有限公司 | Method for preparing isoniazid preparation and preparation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650728B1 (en) * | 1993-10-29 | 2002-02-27 | Council of Scientific and Industrial Research | Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug |
| NZ518216A (en) * | 2000-08-09 | 2004-11-26 | Panacea Biotec Ltd | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
-
2010
- 2010-07-29 RU RU2012105674/15A patent/RU2012105674A/en unknown
- 2010-07-29 AP AP2012006119A patent/AP2012006119A0/en unknown
- 2010-07-29 WO PCT/IB2010/001871 patent/WO2011012987A1/en active Application Filing
-
2012
- 2012-01-26 ZA ZA2012/00659A patent/ZA201200659B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2012006119A0 (en) | 2012-02-29 |
| RU2012105674A (en) | 2013-09-10 |
| WO2011012987A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1231408A1 (en) | Pharmaceutical composition | |
| HK1218881A1 (en) | Pharmaceutical compositions | |
| PT2482812T (en) | Therapeutic uses of pharmaceutical compositions | |
| EP2451274A4 (en) | Pharmaceutical compositions | |
| EP2379077A4 (en) | Pharmaceutical composition | |
| EP2500038A4 (en) | Pharmaceutical composition for external use | |
| ZA201106703B (en) | Use of pharmaceutical compositions containing mesembrenone | |
| HU0900072D0 (en) | Transdermal pharmaceutical compositions | |
| EP2552447A4 (en) | Stable pharmaceutical composition of imatinib | |
| ZA201200659B (en) | Pharmaceutical composition of isoniazid | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| IL219018A0 (en) | Pharmaceutical compositions | |
| EP2543373A4 (en) | Compound pharmaceutical composition of levoamlodipine | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| ZA201200531B (en) | Pharmaceutical composition of rifampicin | |
| HU0900010D0 (en) | Improved pharmaceutical composition | |
| GB0902651D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908069D0 (en) | Pharmaceutical compounds and compositions | |
| GB0901241D0 (en) | Pharmaceutical compositions |